Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) — Cash Flow Reinvestment Rate
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Cash Flow Reinvestment Rate of 0.19x as of December 2025, reinvesting CN¥159.70 Million (capex CN¥152.89 Million plus investments CN¥-6.81 Million) from operating cash flow of CN¥837.18 Million. Explore 301408 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A across 5 annual periods. Also explore 301408 total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Year-by-year capital reinvestment analysis for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A. For live market cap and broader valuation context, see 301408 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | CN¥159.70 Million | CN¥837.18 Million | CN¥152.89 Million | ▼ -32.4% |
| 2024 | 0.28x | CN¥161.29 Million | CN¥571.76 Million | CN¥160.89 Million | ▼ -87.6% |
| 2023 | 2.27x | CN¥298.08 Million | CN¥131.37 Million | CN¥216.31 Million | ▲ +225.7% |
| 2022 | 0.70x | CN¥121.08 Million | CN¥173.84 Million | CN¥104.77 Million | ▲ +89.8% |
| 2021 | 0.37x | CN¥51.68 Million | CN¥140.82 Million | CN¥33.91 Million | — |